- From Neoadjuvant to Adjuvant: Evolving Treatment Paradigms in Early-Stage Breast Cancer
- Evidence-Based Treatment Strategies: CDK4/6i Combination Regimens in HR+ mBC
- Real World Oncology: Translating Data to Clinical Practice
- Sequential Treatment Approaches Following Frontline CDK4/6i in Advanced HR+ Breast Cancer
- Antibody-Drug Conjugates (ADC): Engineering a New Future for Metastatic Breast Cancer
OncLive® State of the Science Summit™ Breast Cancer
The Blake Hotel
9 High Street
New Haven, Connecticut 06510
Tuesday, September 16, 2025
6:00 PM-9:00 PM EDT
Complimentary Parking
In-Person Only
Event Chair
Eric Winer, MD
Yale Cancer Center
IN PARTNERSHIP WITH
OVERVIEW
OncLive® State of the Science Summit™ (SOSS) are in-person meetings designed for academic & community-based physicians and health care professionals that provide education on the science driving updates in cancer management and the associated clinical benefits for patients. SOSS attendees will improve their knowledge of novel treatment approaches and reinforce their confidence in applying state-of-the-art treatment strategies.
Registration for this Summit is complimentary.
TOPICS INCLUDE:
Venue Location
OncLive - an MJH Life Sciences brand
Copyright 2025 (C) Intellisphere, LLC
2 Commerce Drive
Cranbury, NJ 08512